134 related articles for article (PubMed ID: 35284914)
1. PEGylated amphiphilic polymeric manganese(II) complexes as magnetic resonance angiographic agents.
Liu X; Fu S; Xia C; Li M; Cai Z; Wu C; Lu F; Zhu J; Song B; Gong Q; Ai H
J Mater Chem B; 2022 Mar; 10(13):2204-2214. PubMed ID: 35284914
[TBL] [Abstract][Full Text] [Related]
2. Mn(II) complexes of phenylenediamine based macrocyclic ligands as T
Nagendraraj T; Kumaran SS; Mayilmurugan R
J Inorg Biochem; 2022 Mar; 228():111684. PubMed ID: 34929541
[TBL] [Abstract][Full Text] [Related]
3. Mn2+ complexes with 12-membered pyridine based macrocycles bearing carboxylate or phosphonate pendant arm: crystallographic, thermodynamic, kinetic, redox, and 1H/17O relaxation studies.
Drahoš B; Kotek J; Císařová I; Hermann P; Helm L; Lukeš I; Tóth É
Inorg Chem; 2011 Dec; 50(24):12785-801. PubMed ID: 22092039
[TBL] [Abstract][Full Text] [Related]
4. PEGylated Amphiphilic Gd-DOTA Backboned-Bound Branched Polymers as Magnetic Resonance Imaging Contrast Agents.
Fu S; Cai Z; Liu L; Fu X; Xia C; Lui S; Gong Q; Song B; Ai H
Biomacromolecules; 2023 Dec; 24(12):5998-6008. PubMed ID: 37945532
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
6. Mn(II)-Based MRI Contrast Agent Candidate for Vascular Imaging.
Kálmán FK; Nagy V; Váradi B; Garda Z; Molnár E; Trencsényi G; Kiss J; Même S; Même W; Tóth É; Tircsó G
J Med Chem; 2020 Jun; 63(11):6057-6065. PubMed ID: 32372648
[TBL] [Abstract][Full Text] [Related]
7. Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent.
Reale G; Calderoni F; Ghirardi T; Porto F; Illuminati F; Marvelli L; Martini P; Uccelli L; Tonini E; Del Bianco L; Spizzo F; Capozza M; Cazzola E; Carnevale A; Giganti M; Turra A; Esposito J; Boschi A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834877
[TBL] [Abstract][Full Text] [Related]
8. The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents.
Chen A; Sun J; Liu S; Li L; Peng X; Ma L; Zhang R
Biomater Sci; 2020 Jan; 8(1):379-390. PubMed ID: 31728481
[TBL] [Abstract][Full Text] [Related]
9. A Manganese Alternative to Gadolinium for MRI Contrast.
Gale EM; Atanasova IP; Blasi F; Ay I; Caravan P
J Am Chem Soc; 2015 Dec; 137(49):15548-57. PubMed ID: 26588204
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
11. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
[TBL] [Abstract][Full Text] [Related]
12. Mn
Devreux M; Henoumont C; Dioury F; Boutry S; Vacher O; Elst LV; Port M; Muller RN; Sandre O; Laurent S
Inorg Chem; 2021 Mar; 60(6):3604-3619. PubMed ID: 33625836
[TBL] [Abstract][Full Text] [Related]
13. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR
Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic stability and relaxation studies of small, triaza-macrocyclic Mn(II) chelates.
de Sá A; Bonnet CS; Geraldes CF; Tóth É; Ferreira PM; André JP
Dalton Trans; 2013 Apr; 42(13):4522-32. PubMed ID: 23348796
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
[TBL] [Abstract][Full Text] [Related]
16. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
[TBL] [Abstract][Full Text] [Related]
17. A Bis(Aquated) Mn(II)-Based MRI Contrast Agent with a Rigid Hydroquinazoline Unit: Synthesis, Characterization, and
Mallik R; Saha M; Sarmah A; Singh V; Mohan H; Bhat P; Kumaran SS; Mukherjee C
ACS Appl Bio Mater; 2024 Mar; 7(3):1831-1841. PubMed ID: 38427704
[TBL] [Abstract][Full Text] [Related]
18. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
19. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
20. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
